---
figid: PMC5457688__aps2016167f4
figlink: /pmc/articles/PMC5457688/figure/fig4/
number: Figure 4
caption: Précis of signaling pathways involved in glioma and inhibition by mTOR, AKT,
  PI3K and ERK inhibitors and genetic configuration of TSC1 and TSC2. Continuous lines
  with arrow end exhibits activation and with blunt end exhibits inhibition. Growth
  factors up on binding to transmembrane receptors result in PI3Kinase activity which
  elevates PIP3 levels, thus activating AKT leading to anti-apoptotic/pro-cell proliferation
  effects. It has been also reported that HSP90 also phosphorylates AKT. AKT and /or
  ERK upon activation inhibits TSC1/TSC2 complex. But PTEN negatively regulates AKT.
  The C terminal GAP of tuberin inhibits Rheb (G protein, an activator of mTORC1)
  leading to increase in levels of ribosomal S6-kinase and phosphorylated ribosomal
  S6. Drugs potently inhibiting at different level of the signaling pathway has been
  also presented, respectively. The TSC1 gene comprises of 23 exons, 1164 amino acids
  (aa) with 130 kDa molecular mass and interacts with TSC2 in the region of 302–430
  aa. It has coiled-coil (CC, aa 719–998) and potential transmembrane (TM, aa 127–144)
  domains at the N- and C-terminal regions. The TSC2 gene comprises of 41 exons, 1807
  aa with 200 kDa molecular mass and interacts with TSC1 in the region of 1-418 aa.
  The gene also consists of two coiled-coils (CC, aa 346–371 and aa 1008–1021), a
  leucine zipper (LZ, aa 75–107), a Rheb-GAP (aa 1517–1674) and a calmodulin-binding
  (CAM, aa 1740–1758) domain. The N-terminal CC domain is essential for its association
  with TSC1. At specific aa residues the activity of TSC1 and TSC2 is synchronized
  by both inhibitory and activating phosphorylation events. In TSC1, the presence
  of glycogen synthase 3 beta (GSK3B) sites Thr357 and Thr390 activates and presence
  of cyclin dependent kinase (CDK1) sites Thr417, Ser584, and Thr1047 inhibits TSC1-TSC2
  complex activity. In TSC2, the presence of AMP kinase (AMPK) sites Thr1227 and Ser1345
  activates and presence of extracellular-related kinase (ERK2) sites Ser664; AKT/protein
  kinase B (PKB) sites Ser939, Ser981, Thr1462; mitogen-activated protein kinase-
  activated protein kinase 2 (MK2) site Ser1210 and p90 ribosomal S6 kinase 1 (RSK1)
  site Ser1798 inhibits TSC1-TSC2 complex activity.
pmcid: PMC5457688
papertitle: 'Insights into molecular therapy of glioma: current challenges and next
  generation blueprint.'
reftext: Y Rajesh, et al. Acta Pharmacol Sin. 2017 May;38(5):591-613.
pmc_ranked_result_index: '230013'
pathway_score: 0.9593516
filename: aps2016167f4.jpg
figtitle: Précis of signaling pathways involved in glioma and inhibition by mTOR,
  AKT, PI3K and ERK inhibitors and genetic configuration of TSC1 and TSC2
year: '2017'
organisms: Homo sapiens
ndex: 8580a655-dee1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5457688__aps2016167f4.html
  '@type': Dataset
  description: Précis of signaling pathways involved in glioma and inhibition by mTOR,
    AKT, PI3K and ERK inhibitors and genetic configuration of TSC1 and TSC2. Continuous
    lines with arrow end exhibits activation and with blunt end exhibits inhibition.
    Growth factors up on binding to transmembrane receptors result in PI3Kinase activity
    which elevates PIP3 levels, thus activating AKT leading to anti-apoptotic/pro-cell
    proliferation effects. It has been also reported that HSP90 also phosphorylates
    AKT. AKT and /or ERK upon activation inhibits TSC1/TSC2 complex. But PTEN negatively
    regulates AKT. The C terminal GAP of tuberin inhibits Rheb (G protein, an activator
    of mTORC1) leading to increase in levels of ribosomal S6-kinase and phosphorylated
    ribosomal S6. Drugs potently inhibiting at different level of the signaling pathway
    has been also presented, respectively. The TSC1 gene comprises of 23 exons, 1164
    amino acids (aa) with 130 kDa molecular mass and interacts with TSC2 in the region
    of 302–430 aa. It has coiled-coil (CC, aa 719–998) and potential transmembrane
    (TM, aa 127–144) domains at the N- and C-terminal regions. The TSC2 gene comprises
    of 41 exons, 1807 aa with 200 kDa molecular mass and interacts with TSC1 in the
    region of 1-418 aa. The gene also consists of two coiled-coils (CC, aa 346–371
    and aa 1008–1021), a leucine zipper (LZ, aa 75–107), a Rheb-GAP (aa 1517–1674)
    and a calmodulin-binding (CAM, aa 1740–1758) domain. The N-terminal CC domain
    is essential for its association with TSC1. At specific aa residues the activity
    of TSC1 and TSC2 is synchronized by both inhibitory and activating phosphorylation
    events. In TSC1, the presence of glycogen synthase 3 beta (GSK3B) sites Thr357
    and Thr390 activates and presence of cyclin dependent kinase (CDK1) sites Thr417,
    Ser584, and Thr1047 inhibits TSC1-TSC2 complex activity. In TSC2, the presence
    of AMP kinase (AMPK) sites Thr1227 and Ser1345 activates and presence of extracellular-related
    kinase (ERK2) sites Ser664; AKT/protein kinase B (PKB) sites Ser939, Ser981, Thr1462;
    mitogen-activated protein kinase- activated protein kinase 2 (MK2) site Ser1210
    and p90 ribosomal S6 kinase 1 (RSK1) site Ser1798 inhibits TSC1-TSC2 complex activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RPTOR
  - MTOR
  - RICTOR
  - RPS6KA6
  - RPS6KA1
  - RPS6KA2
  - MLST8
  - RHEB
  - MAPK12
  - PIK3R3
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R4
  - RPS6KA3
  - NRAS
  - TSC2
  - MAPK1
  - AKT3
  - PIK3CB
  - KRIT1
  - EIF4EBP1
  - MAPKAP1
  - AKT1
  - TSC1
  - AKT1S1
  - MAPK10
  - MAPK13
  - AKT2
  - KRAS
  - RPS6KB1
  - PTEN
  - RASA1
  - PIK3R5
  - BRAF
  - PDK1
  - MAPK9
  - ARAF
  - RAF1
  - THRA
  - PIK3R6
  - HRAS
  - MAPK11
  - RPS6KA4
  - RPS6KB2
  - HSP90B1
  - TRAP1
  - MAPK3
  - THRB
  - MAPK8
  - RPS6KA5
  - HSP90AB1
  - MAPK14
  - benzimidazole
  - Perifosine
  - enzastaurin
  - Glucose
  - Ser
  - Thr
  - Rapamycin
  - Cancer
  - Lung cancer
genes:
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: '>RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: (ERK2)
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CAM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: '>RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: →PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: GAP
  symbol: GAP
  source: hgnc_alias_symbol
  hgnc_symbol: RASA1
  entrez: '5921'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RÁF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RÁF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RÁF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRA
  entrez: '7067'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: '>RAS'
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Thr
  symbol: THR
  source: bioentities_symbol
  hgnc_symbol: THRB
  entrez: '7068'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RSK
  symbol: RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
chemicals:
- word: benzimidazole
  source: MESH
  identifier: C031000
- word: Perifosine
  source: MESH
  identifier: C105905
- word: enzastaurin
  source: MESH
  identifier: C504878
- word: Glucose
  source: MESH
  identifier: D005947
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
